Key facts
- It has raised $31.0M across 1 recorded rounds; the latest was Early Stage VC ($6.0M) in Nov 2020.
- Notable investors include 515 Ventures, Accomplice VC, Digitalis Ventures, Life Extension Ventures, Massachusetts Mutual Life Insurance — 17 tracked in total.
- Onc AI has filed 1 Form D with the SEC, most recently Dec 2020 ($6.0M sold to 26 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Onc AI
Funding rounds
1 roundsAbout Onc AI
Developer of a deep learning imaging platform designed to improve oncology decision-making through enhanced analysis of diagnostic scans. The company's platform offers radiomic-based AI models integrated with real-world clinical data and a cloud-based analytics interface, enabling oncologists and pharmaceutical researchers to optimize treatment planning and trial outcomes with predictions of patient response and survival.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2020
- Employees
- 26
- Website
- onc.ai/
- Ownership
- Privately Held (backing)
Onc AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Onc AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Onc AI in its N-PORT filings yet. We sweep new filings monthly.